FRI0474 The Three-Year Outcome of Infliximab (IFX), an Anti-TNF-α Antibody, in Patients with Refractory Intestinal-BehÇEt's Disease (BD)
2014 ◽
Vol 73
(Suppl 2)
◽
pp. 559.1-559
2013 ◽
Vol 71
(Suppl 3)
◽
pp. 392.2-392
2014 ◽
Vol 8
(7)
◽
pp. 714-715
◽
2001 ◽
Vol 16
◽
pp. 19-19
2016 ◽
Vol 75
(Suppl 2)
◽
pp. 405.2-405
1999 ◽
Vol 32
(5)
◽
pp. 1222-1226
◽
2011 ◽
Vol 50
(5)
◽
pp. 429-432
◽